S&P Futures
5,746.00 +2.75 (+0.05%) Dow Futures
41,991.00 +35.00 (+0.08%) Nasdaq Futures
20,098.75 +12.75 (+0.06%) Russell 2000 Futures
2,229.30 -1.80 (-0.08%) Crude Oil
71.53 +0.06 (+0.08%) Gold
2,744.30 -1.90 (-0.07%)
DRI Healthcare Trust (DHT-UN.TO)
| Previous Close | 13.82 |
| Open | 13.78 |
| Bid | 13.99 x N/A |
| Ask | 14.03 x N/A |
| Day's Range | 13.34 - 14.20 |
| 52 Week Range | 7.99 - 14.20 |
| Volume | |
| Avg. Volume | 838 |
| Market Cap | 796.671M |
| Beta (5Y Monthly) | 0.60 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.06 |
| Earnings Date | Nov 06, 2024 |
| Forward Dividend & Yield | 0.47 (3.39%) |
| Ex-Dividend Date | Sep 27, 2024 |
| 1y Target Est | 19.47 |
CNW GroupDRI Healthcare Trust Announces Acquisition of a Synthetic Royalty Interest in the Worldwide Sales of Sebetralstat for the Treatment of Hereditary Angioedema Plus an Equity Investment in KalVista Pharmaceuticals
DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust"), a global leader in providing financing to advance innovation in the life sciences industry, has acquired a royalty interest in the worldwide net sales of all formulations of sebetralstat from KalVista Pharmaceuticals ("KalVista") for an aggregate purchase price of up to US$179 million, comprised of a US$100 million upfront payment, up to US$57 million in a sales-based milestone payment and a one-time US$22 million optional payment. A
CNW GroupDRI Healthcare Trust Announces Upsized US$631.6 Million Credit Facilities
DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust"), a global leader in providing financing to advance innovation in the life sciences industry, has entered into an amendment agreement to the existing amended and restated credit agreement (the "Agreement") with a syndicate of banks providing up to US$631.6 million of debt capacity. As part of the amendment, the interest rate on drawings was reduced by 0.25% based on the Trust's leverage ratio. The facilities are secured by all of the a
